Bio-Outsourcing

59 Results

Process optimization for mAb commercial manufacturing

Process optimization for mAb commercial manufacturing

Content provided by Catalent | 01-Jun-2023 | Product Presentation

Process characterization and validation is an important step in the product development journey and late-phase development, and it is required before transferring...

Impurity profiling and analysis of TheraPure GMP nucleotides

Impurity profiling and analysis of TheraPure GMP nucleotides

Content provided by Thermo Fisher Scientific - Biosciences | 22-Mar-2023 | White Paper

Nucleoside triphosphates (NTPs) are vital components of emerging RNA therapeutics and vaccines. Controlling impurities that may be present in them while...

eBook: mRNA prospects and scale-up solutions

eBook: mRNA prospects and scale-up solutions

Content provided by Thermo Fisher Scientific - Biosciences | 22-Mar-2023 | Insight Guide

This mRNA eBook was created by Thermo Fisher Scientific, in collaboration with Genetic Engineering & Biotechnology News (GEN), to provide you with...

Create Better Biologic Treatments with Catalent

Create Better Biologic Treatments with Catalent

Content provided by Catalent | 21-Feb-2023 | Product Brochure

Deliver safe and stable products to your patients with the help of Catalent Biologics' Limoges, France site, a European Center of Excellence for early-phase...

Trends in Biopharmaceutical Raw Material Selection

Trends in Biopharmaceutical Raw Material Selection

Content provided by Actylis – The Partner of Choice | 31-Jan-2023 | Business Advice

Join us as our in-house experts, along with Cecile Bellamy from Pfizer, discuss current and future trends in biopharmaceutical raw material selection.

Supporting first lyophilised mRNA vaccine to trial

Supporting first lyophilised mRNA vaccine to trial

Content provided by Recipharm AB | 28-Nov-2022 | Case Study

When Arcturus presented its mRNA vaccine candidate to Recipharm, it was at the stage of a frozen product, a ready-to-administer sterile injectable for...

Liposomal and Nanoparticle Technology

Liposomal and Nanoparticle Technology

Content provided by Pfizer CentreOne | 18-Nov-2022 | White Paper

Medical science is continuously searching for better ways to administer drugs into the body and to maximize the therapeutic effectiveness of the drugs...

GMP manufacturing of buffers and liquid blends

GMP manufacturing of buffers and liquid blends

Content provided by Actylis – The Partner of Choice | 16-Nov-2022 | White Paper

Actylis manufactures buffers, process solutions, cleaning solutions, Water for Injection (WFI) for further processing, and custom liquid blends in compliance...

Custom manufacturing of protease inhibitor PMSF

Custom manufacturing of protease inhibitor PMSF

Content provided by Actylis – The Partner of Choice | 09-Nov-2022 | White Paper

By combining 75+ years of manufacturing and sourcing expertise, Actylis provides a wide portfolio of GMP ingredients to the pharma & biopharma market,...

Discover Catalent Biologics’ Premier European Site

Discover Catalent Biologics’ Premier European Site

Content provided by Catalent | 01-Nov-2022 | Product Brochure

Catalent Biologics’ Anagni, Italy facility is a world-class, late-stage, and commercial product launch site offering sterile and biologics manufacturing...

Choose Catalent to Launch Your Biologics in Europe

Choose Catalent to Launch Your Biologics in Europe

Content provided by Catalent | 25-Oct-2022 | Product Brochure

With over 30 years of experience producing sterile drug products, Catalent Biologics is your premier manufacturing and packaging partner in Europe. We...

dPCR Case Study

dPCR Case Study

Content provided by CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Content provided by Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Content provided by Altasciences | 10-May-2022 | White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Content provided by Baxter BioPharma Solutions | 16-Feb-2022 | White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Content provided by Baxter BioPharma Solutions | 16-Feb-2022 | White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Partner with Experts in Precision Medicine

Partner with Experts in Precision Medicine

Content provided by CellCarta | 17-Jan-2022 | Product Brochure

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

High quality excipients and formulation support

High quality excipients and formulation support

Content provided by Roquette Pharma Solutions | 09-Nov-2021 | Product Brochure

As the world grapples with the effects of ongoing health crises, the market is expanding quickly as developers shift their focus to proactive therapeutics....

Rapid Biosafety Testing Enables the Future of Manufacturing

Rapid Biosafety Testing Enables the Future of Manufacturing

Content provided by Viral Safety for mAb: Prevent, Detect, Remove | 23-Nov-2020 | White Paper

This white paper explores the factors driving the evolution toward faster biosafety testing and describes rapid approaches for adventitious agent testing...

Blazar™ Platform: Rodent Virus Panel

Blazar™ Platform: Rodent Virus Panel

Content provided by Viral Safety for mAb: Prevent, Detect, Remove | 16-Nov-2020 | White Paper

We have a long history of developing innovative molecular technologies for cell line characterization and lot release testing for the biopharmaceutical...

Monitoring SARS-CoV-2 interaction with ACE2

Monitoring SARS-CoV-2 interaction with ACE2

Content provided by Take the Right Path Upstream with MilliporeSigma | 02-Nov-2020 | White Paper

In this technical note, we investigate the interactions between the following: The spike glycoprotein binding with ACE2, Spike glycoprotein and anti-spike...

CDMO Process Development Template

CDMO Process Development Template

Content provided by MilliporeSigma - Gene Therapy | 26-Oct-2020 | Infographic

Process development is a crucial step in viral vector manufacturing and a successful CDMO partnership can help navigate the challenges associated with...

Infographic - road map to commercialization

Infographic - road map to commercialization

Content provided by MilliporeSigma - Gene Therapy | 19-Oct-2020 | Infographic

With the current increase in development and investment, gene therapy companies will increasingly be looking to streamline the manufacture and commercialization...

Process Development for Viral Vector Manufacturing

Process Development for Viral Vector Manufacturing

Content provided by MilliporeSigma - Gene Therapy | 15-Oct-2020 | Infographic

Process development is a crucial step in viral vector manufacturing and a successful CDMO partnership can help navigate the challenges associated with...

Accelerating Cell Line and Process Development

Accelerating Cell Line and Process Development

Content provided by Take the Right Path Upstream with MilliporeSigma | 01-Oct-2020 | White Paper

Development of a high-producing cell line supported by a robust upstream process are critical early steps in the production of monoclonal antibodies (mAbs)....

Strategies for Upstream Intensification

Strategies for Upstream Intensification

Content provided by Take the Right Path Upstream with MilliporeSigma | 01-Sep-2020 | White Paper

The Facility of the Future represents a transformation in how biologics are developed and manufactured.

High-Density Vero Cell Perfusion Culture

High-Density Vero Cell Perfusion Culture

Content provided by Eppendorf Bioprocess Solutions | 01-May-2018 | Application Note

Viral diseases like rabies, rotavirus and influenza are causing many deaths worldwide, resulting in a strong demand for more productive manufacturing techniques...

The Next Stage – Eppendorfs new Mastercycler X50

The Next Stage – Eppendorfs new Mastercycler X50

Content provided by Eppendorf Bioprocess Solutions | 05-Sep-2017 | Application Note

The Mastercycler X50 is Eppendorf's new PCR cycler with lots of new benefits. Not only can you heat with 10°C/s, you can also optimize two different...

lyo_development

Best Practices in Formulation and Lyo Development

Content provided by Baxter BioPharma Solutions | 13-Feb-2017 | White Paper

The ultimate goal of formulation development is a stable product. In the case of a protein product, that can be defined as delivering the correct dose,...

SGS-LSS

Functional Comparability of a Biosimilar

Content provided by SGS | 19-Sep-2016 | White Paper

Regulatory authorities require head-to-head comparison at multiple levels to demonstrate that a proposed biosimilar is “similar or highly similar” to the...

Suppliers

Follow us

Product Innovations